Prolonged heparin after uncomplicated coronary interventions: A prospective, randomized trial

This publication has 22 references indexed in Scilit:

• More evidence for a beneficial effect of platelet glycoprotein IIb/IIIa-blockade during coronary interventions. Latest results from the EPILOG and CAPTURE trials
  European Heart Journal, 1996
• Randomized prospective evaluation of prolonged versus abbreviated intravenous heparin therapy after coronary angioplasty
  JACC, 1994
• Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
  New England Journal of Medicine, 1994
• Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty).
  Circulation, 1993
• Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up.
  Circulation, 1991
• Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.
  Circulation, 1990
• Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombus
  The American Journal of Cardiology, 1990
• Acute coronary occlusion occurring after successful percutaneous transluminal coronary angioplasty: Temporal relationship to discontinuation of anticoagulation
  American Heart Journal, 1988
• Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.
  Circulation, 1987
• Frequency, management and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplasty
  The American Journal of Cardiology, 1987